Leerink Partners analyst Thomas Smith has reiterated their bullish stance on VKTX stock, giving a Buy rating yesterday. Thomas Smith has given his Buy rating due to a combination of factors, primarily ...

The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $62.45, representing a -0.3% change from its previous close.

In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Viking Therapeutics (VKTX – Research Report). The ...

We recently compiled a list of the 10 Best Hot Stocks To Buy Right Now. In this article, we are going to take a look at where ...

On Monday, Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $63.01 which represents a decrease of $-1.95 or -3.00% from the prior close of $64.96. The stock opened at $65.61 and ...

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $64.96, denoting a +1.33% change from the preceding trading day.

Viking Therapeutics Inc (VKTX) stock saw a decline, ending the day at $64.11 which represents a decrease of $-0.58 or -0.90% from the prior close of $64.69. The stock opened at $64.6 and touched a low ...

Viking Therapeutics Inc. on Wednesday reported positive data from an early-stage trial of a treatment for the rare, and often ...

Below is a chart showing BILL's trailing twelve month trading history, with the $70 strike highlighted in orange: And Viking Therapeutics Inc (Symbol: VKTX) options are showing a volume of 15,384 ...

Viking Therapeutics, Inc. (VKTX) closed the most recent trading day at $64.96, moving +1.33% from the previous trading session. This change outpaced the S&P 500's 0.9% gain on the day. On the ...

On Wednesday, Viking Therapeutics Inc. (NASDAQ:VKTX) released data from the Phase 1b trial of VK0214, a novel small molecule ...